5-CYANO-N,N,N-TRIMETHYL-2-((5R)-2,3,5,8-TETRAHYDRO-6-(METHOXYCARBONYL)-7-METHYL-3-OXO-8-(3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-TRIAZOLO(4,3-A)PYRIMIDIN-5-YL)BENZENEETHANAMINIUM XINAFOATE
UNII H88K34CEV9
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-cyano-n,n,n-trimethyl-2-((5r)-2,3,5,8-tetrahydro-6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-1,2,4-triazolo(4,3-a)pyrimidin-5-yl)benzeneethanaminium Xinafoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H88K34CEV9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3071964-44-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H28F3N6O3.C11H7O3 YHTRTIHMDPAQKX-GNAFDRTKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-cyano-n,n,n-trimethyl-2-((5r)-2,3,5,8-tetrahydro-6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-1,2,4-triazolo(4,3-a)pyrimidin-5-yl)benzeneethanaminium Xinafoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.